|
signaling receptor inhibitor activity
|
GO_0030547 |
|
|
protein tyrosine kinase inhibitor activity
|
GO_0030292 |
|
|
receptor signaling protein tyrosine kinase inhibitor activity
|
GO_0030294 |
|
|
protein kinase activator activity
|
GO_0030295 |
|
|
kinase activator activity
|
GO_0019209 |
|
|
protein tyrosine kinase activator activity
|
GO_0030296 |
|
|
transmembrane receptor protein tyrosine kinase activator activity
|
GO_0030297 |
|
|
signaling receptor activator activity
|
GO_0030546 |
|
|
receptor signaling protein tyrosine kinase activator activity
|
GO_0030298 |
|
|
intestinal cholesterol absorption
|
GO_0030299 |
|
|
intestinal lipid absorption
|
GO_0098856 |
|
|
cholesterol transport
|
GO_0030301 |
|
|
sphingolipid activator protein activity
|
GO_0030290 |
|
|
protein serine/threonine kinase inhibitor activity
|
GO_0030291 |
|
|
protein kinase inhibitor activity
|
GO_0004860 |
|
|
bone mineralization
|
GO_0030282 |
|
|
biomineral tissue development
|
GO_0031214 |
|
|
testosterone dehydrogenase [NAD(P)] activity
|
GO_0030283 |
|
|
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
GO_0033764 |
|
|
estrogen receptor activity
|
GO_0030284 |
|
